Pacira reported $3.83B in Stock for its fiscal quarter ending in September of 2026.



Stock Change Date
Astellas Pharma JPY 337.89B 6.87B Jun/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Cara Therapeutics USD 900K 0 Mar/2025
Coherus Biosciences USD 5.67M 842K Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
J&J USD 15.38B 233M Sep/2026
Ligand Pharmaceuticals USD 14.51M 4.24M Sep/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Omeros USD 712K 266K Sep/2021
Perrigo USD 1.01B 50.7M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Supernus Pharmaceuticals USD 113.24M 6.22M Sep/2026
Teva Pharmaceutical Industries USD 3.17B 48M Sep/2026
Xeris Pharmaceuticals USD 76.92M 4M Sep/2026
Zoetis USD 2.54B 38M Sep/2026